. 2020 Jun 1:10.14309/ajg.0000000000000717. doi: 10.14309/ajg.0000000000000717
© 2020 by The American College of Gastroenterology
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
Table 1.
Characteristics of 222 liver enzyme elevation patients in a cohort of 788 patients with COVID-19
